Clinical meaning
Metastatic bone disease occurs when cancer cells disseminate hematogenously to the bone marrow and establish secondary tumor deposits, most commonly from primary cancers of the breast, prostate, lung, kidney, and thyroid. The normal bone remodeling cycle is disrupted: osteolytic metastases (breast, lung, kidney) secrete factors (PTHrP, RANKL, IL-6) that stimulate osteoclast-mediated bone resorption, releasing growth factors stored in the bone matrix (TGF-beta, IGF) that further stimulate tumor growth in a 'vicious cycle.' Osteoblastic metastases (prostate) secrete factors (endothelin-1, BMPs) that stimulate excessive disorganized bone formation. Complications include pathological fractures (long bones, vertebrae), spinal cord compression (oncological emergency requiring emergent MRI and intervention within 24-48 hours), hypercalcemia from osteolytic activity, and bone marrow failure from marrow replacement. The nurse assesses for bone pain (deep, constant, worse at night), monitors for signs of spinal cord compression (back pain, bilateral leg weakness, sensory level, bowel/bladder dysfunction), implements fall prevention and safe mobilization protocols, administers prescribed bisphosphonates or denosumab, manages pain with a multimodal approach, and coordinates radiation therapy for painful metastases.